dihydroxyphenylalanine has been researched along with Catatonic Schizophrenia in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lauer, M | 1 |
| Schirrmeister, H | 1 |
| Gerhard, A | 1 |
| Ellitok, E | 1 |
| Beckmann, H | 1 |
| Reske, SN | 1 |
| Stöber, G | 1 |
1 other study available for dihydroxyphenylalanine and Catatonic Schizophrenia
| Article | Year |
|---|---|
Disturbed neural circuits in a subtype of chronic catatonic schizophrenia demonstrated by F-18-FDG-PET and F-18-DOPA-PET.
Topics: Adult; Brain; Chronic Disease; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F1 | 2001 |